Roivant scores in interstitial lung disease Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

M Tue W Th F 8 September, 2026

Connect with the people shaping biotech’s future and gain the industry intelligence you need to plan for 2027 at MassBio’s Align Summit. sponsored by MassBio

news Updated: Novartis sinks after second disastrous trial failure, this time of Avidity-acquired drug •  Novartis' Phase 3 cardiovascular study miss raises the stakes for Amgen, Lilly Roivant reports Phase 2 win for lung disease drug that it got from Bayer BrainChild Bio gets $116M for pivotal trial of pediatric brain tumor CAR-T Beam says AATD base editing data hold up after one year Diabetes cell therapy biotechs Sernova and Seraxis to merge

More Stories Updated: Novo Nordisk cans 2 more trials of IL-6 heart drug for futility FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote AbbVie-allied ADARx aims for IPO with three drugs in the clinic Claret says its latest fund will have larger focus on European life sciences

Sep 10 11:00 am ET Inside the IDMO model: Analytical comparability, regulatory readiness and operational excellence sponsored by Cellares Sep 16 2:00 pm ET Beyond ICD codes: Unlocking rare disease insights with genomics and claims-based data sponsored by GeneDx Sep 22 12:00 pm ET The future of drug pricing: Medicare negotiation, MFN models & beyond sponsored by ADVI Oct 20 11:00 am ET Intelligent oversight and orchestration: How mission control is redefining R&D decision-making sponsored by ZS Oct 22 11:00 am ET A new model for clinical research – Expanding community trial access sponsored by Parexel

China’s biotech rise is forcing Washington’s hand. We’ll sit down with the policymakers deciding how the US answers and how it speeds up its own drug development. Get your spot now.

in case you missed it 1. A global health cash crunch could jeopardize the race for new Ebola vaccines 2. Former I-Mab chief Joan Shen's NeuShen banks $80M+ for 3 brain-health drugs 3. Ionis wins FDA clearance for Alexander disease drug, company's first solo neurology approval 4. Patients are flying to China for the latest cancer treatment 5.